Basel, April 30, 2018 – Novartis announced new positive brolucizumab (RTH258) data in neovascular age-related macular degeneration (nAMD) from a pre-specified secondary analysis of the Phase III HAWK and HARRIER trials. The findings showed that patients assessed as appropriate for a 12-week treatment frequency during the first 12-week cycle after loading could reliably stay on […]Continue Reading ...
April 12, 2018 The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association for Cancer Research (AACR) 2018 Annual Meeting in Chicago. Ciclopirox Prodrug was discovered by researchers at The University of Kansas Cancer Center and KU’s Institute […]Continue Reading ...
March 1, 2018 Fear protects people from danger. A team from the Technical University of Munich (TUM) and Helmholtz Zentrum München has discovered that this applies even to pathological anxiety disorders. Patients who generally suffer from severe anxiety are likely to heed the symptoms of a heart attack earlier and seek medical treatment sooner, thus […]Continue Reading ...
March 1, 2018 Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes. That gene, KRAS, is mutated in approximately 20 percent of all human cancers and has a major presence in […]Continue Reading ...
March 2, 2018 A metal plate might be the cure for a common foot injury seen in athletes and people on their feet all day, according to new research conducted at Houston Methodist. In a paper published online February 21 by The American Journal of Sports Medicine, researchers led by Kevin Varner, M.D., a Houston […]Continue Reading ...
March 2, 2018 New research has found no evidence Omega-3 fish oil supplements help aid or improve the reading ability or memory function of underperforming school-children. These findings are in contradiction to an earlier study run by the same team using the same supplement. In the second high-quality trial of its kind, published in PLOS-ONE, […]Continue Reading ...
Gilead’s Biktarvy Cleared for Use in HIV-1 Infection In February, the FDA approved Gilead’s Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide, or BIC/FTC/TAF), a combination, once-daily, oral treatment for HIV-1 infection in adults. Biktarvy is used for the treatment of two HIV groups: either those who have no antiretroviral treatment history or those who are virologically […]Continue Reading ...
NORTH CHICAGO, Ill., Feb. 16, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today announced new results from the double-blinded extension phase of the Phase 2 CELEST study, showing that many patients treated with upadacitinib who achieved clinical response after the 16-week induction phase maintained their response to treatment after […]Continue Reading ...
March 15, 2018 A study by the Harvard Pilgrim Health Care Institute found that contrary to current hepatitis C treatment guidelines, an eight-week treatment regimen may be just as effective as 12 weeks in black patients. The new study of more than 2,600 patients in Kaiser Permanente’s Northern California region also showed that more people […]Continue Reading ...
Credit: CC0 Public Domain A diet rich in saturated fat and sugar not only leads to obesity, it creates inflammation in the nucleus accumbens, a part of the brain that controls mood and the feeling of reward. And this inflammation can lead to depressive, anxious and compulsive behaviour and disrupt metabolism, according to a new […]Continue Reading ...
Sorrento Therapeutics Subsidiary, Scilex, Receives FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for Post-Herpetic Neuralgia Pain SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), and its majority-owned subsidiary, Scilex Pharmaceuticals Inc. (“Scilex”), received approval from the U.S. Food and Drug Administration (FDA) for ZTlido (lidocaine topical system) 1.8%. […]Continue Reading ...
ATLANTA — Hepatitis A vaccination should be given following exposure in all persons ages 12 months and older, the Advisory Committee on Immunization Practices (ACIP) said. In a unanimous 14-0 vote, the ACIP voted that “hepatitis A vaccines should be administered as post-exposure prophylaxis,” for this population, and immune globulin should be administered to adults […]Continue Reading ...
Credit: Yale University Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes. That gene, KRAS, is mutated in approximately 20 percent of all human cancers and has a major presence in […]Continue Reading ...
February 27, 2018 Health authorities will need to focus on more than eating habits if they are going to combat the obesity epidemic. A study led by the University of Waterloo found it’s generally a combination of unhealthy behaviors among youth that could be the greatest predictors of whether or not young people will experience […]Continue Reading ...
Credit: University of Liverpool A new study, published in the Addiction journal, conducted by researchers from the University of Liverpool highlights the ineffectiveness of a specific drug treatment for alcohol use disorders. Baclofen is a medication which has been used since the 1970s as an anti-spasticity treatment. More recently it has been used as a […]Continue Reading ...
- Breast cancer survivors do not receive recommended level of screening after surgery
- Recommendations Developed for Managing Postpartum Pain
- Rheumatoid Arthritis (RA) | Arthritis Basics | Arthritis Types | Arthritis
- ‘Life support’ for transplant livers better than freezing: study
- Tree nut consumption linked to improved type 2 diabetes health
- Income and education gap causes racial differences in health behaviors, study shows
- Even at ‘Safe’ Levels, Air Pollution Puts Seniors at Risk
- Obstructive sleep apnea linked to thinning of calvaria, skull base
- Epigem’s Managing Director sets the bar for life sciences industry at VentureFest
- CPAP may reduce resting heart rate in prediabetic patients
- Study reveals striking disparities in health care access and quality across most nations
- The Yogi masters were right—meditation and breathing exercises can sharpen your mind
- SLU researcher aims to find solutions for diabetes patients at risk of hypoglycemia
- Scientists uncover the cause of insulin resistance in obesity
- $2.3 million NIH grant to support new project on oxytocin neurons and social behavior
- Less Driving Tied to Lower Cardiovascular Disease Risk
- Genetics Home Reference: LMNA-related congenital muscular dystrophy
- Long-term psychological study confirms time is the best medicine against homesickness
- Study explores if CPAP treatment can improve sexual QOL for sleep apnea patients
- Study investigates role played by brain in prosocial behavior